Literature DB >> 20223258

Development of a sensitive enzyme immunoassay for measuring taipan venom in serum.

S Kulawickrama1, M A O'Leary, W C Hodgson, S G A Brown, T Jacoby, K Davern, G K Isbister.   

Abstract

The detection and measurement of snake venom in blood is important for confirming snake identification, determining when sufficient antivenom has been given, detecting recurrence of envenoming, and in forensic investigation. Venom enzyme immunoassays (EIA) have had persistent problems with poor sensitivity and high background absorbance leading to false positive results. This is particularly problematic with Australasian snakes where small amounts of highly potent venom are injected, resulting in low concentrations being associated with severe clinical effects. We aimed to develop a venom EIA with a limit of detection (LoD) sufficient to accurately distinguish mild envenoming from background absorbance at picogram concentrations of venom in blood. Serum samples were obtained from patients with taipan bites (Oxyuranus spp.) before and after antivenom, and from rats given known venom doses. A sandwich EIA was developed using biotinylated rabbit anti-snake venom antibodies for detection. For low venom concentrations (i.e. <1 ng/mL) the assay was done before and after addition of antivenom to the sample (antivenom difference method). The LoD was 0.15 ng/mL for the standard assay and 0.1 ng/mL for the antivenom difference method. In 11 pre-antivenom samples the median venom concentration was 10 ng/mL (Range: 0.3-3212 ng/mL). In four patients with incomplete venom-induced consumption coagulopathy the median venom concentration was 2.4 ng/mL compared to 30 ng/mL in seven patients with complete venom-induced consumption coagulopathy. No venom was detected in any post-antivenom sample and the median antivenom dose prior to this first post-antivenom sample was 1.5 vials (1-3 vials), including 7 patients administered only 1 vial. In rats the assay distinguished a 3-fold difference in venom dose administered and there was small inter-individual variability. There was small but measurable cross-reactivity with black snake (Pseudechis), tiger snake (Notechis) and rough-scale snake (Tropidechis carinatus) venoms with the assay for low venom concentrations (<1 ng/mL). The use of biotinylation and the antivenom difference method in venom EIA produces a highly sensitive assay that will be useful for determining antivenom dose, forensic and clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223258     DOI: 10.1016/j.toxicon.2010.03.003

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  21 in total

1.  Clinical toxinology.

Authors:  Julian White
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

2.  Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).

Authors:  Christopher I Johnston; Margaret A O'Leary; Simon G A Brown; Bart J Currie; Lambros Halkidis; Richard Whitaker; Benjamin Close; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

3.  A randomised controlled trial of two infusion rates to decrease reactions to antivenom.

Authors:  Geoffrey K Isbister; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Ariaranee Ariaratnam
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

4.  Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy.

Authors:  Geoffrey K Isbister; Kalana Maduwage; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Margaret A O'Leary; Christeine A Gnanathasan; Lisa F Lincz
Journal:  PLoS Negl Trop Dis       Date:  2015-08-21

5.  Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.

Authors:  Geoffrey K Isbister; Kalana Maduwage; Ana Saiao; Nicholas A Buckley; Shaluka F Jayamanne; Shahmy Seyed; Fahim Mohamed; Umesh Chathuranga; Alexandre Mendes; Chandana Abeysinghe; Harindra Karunathilake; Indika Gawarammana; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-07-02

Review 6.  Diagnosis of snakebite and the importance of immunological tests in venom research.

Authors:  R David G Theakston; Gavin D Laing
Journal:  Toxins (Basel)       Date:  2014-05-23       Impact factor: 4.546

7.  Detection of venom after antivenom is not associated with persistent coagulopathy in a prospective cohort of Russell's viper (Daboia russelii) envenomings.

Authors:  Kalana Maduwage; Margaret A O'Leary; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harindra Karunathilake; Lisa F Lincz; Christeine A Gnanathasan; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

8.  Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies.

Authors:  Kalana Maduwage; Anjana Silva; Margaret A O'Leary; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

9.  Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14).

Authors:  George E Allen; Simon G A Brown; Nicholas A Buckley; Margaret A O'Leary; Colin B Page; Bart J Currie; Julian White; Geoffrey K Isbister
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation.

Authors:  Shelley F Stone; Geoffrey K Isbister; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Ariaranee Ariaratnam; Tamara E Jacoby-Alner; Claire L Cotterell; Simon G A Brown
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.